Premium
An intragenic long noncoding RNA interacts epigenetically with the RUNX1 promoter and enhancer chromatin DNA in hematopoietic malignancies
Author(s) -
Wang Hong,
Li Wei,
Guo Rui,
Sun Jingnan,
Cui Jiuwei,
Wang Guanjun,
Hoffman Andrew R.,
Hu JiFan
Publication year - 2014
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.28922
Subject(s) - chromatin , enhancer , biology , runx1 , haematopoiesis , rna , dna , long non coding rna , genetics , dna methylation , epigenetics , cancer research , gene , transcription factor , stem cell , gene expression
RUNX1 , a master regulator of hematopoiesis, is the most commonly perturbed target of chromosomal abnormalities in hematopoietic malignancies. The t(8;21) translocation is found in 30–40% of cases of acute myeloid leukemia (AML). Recent whole‐exome sequencing also reveals mutations and deletions of RUNX1 in some solid tumors. We describe a RUNX1 ‐intragenic long noncoding RNA RUNXOR that is transcribed as unspliced transcript from an upstream overlapping promoter. RUNXOR was upregulated in AML samples and in response to Ara‐C treatment in vitro. RUNXOR utilizes its 3′‐terminal fragment to directly interact with the RUNX1 promoter and enhancers and participates in the orchestration of an intrachromosomal loop. The 3′ region of RUNXOR also participates in long‐range interchromosomal interactions with chromatin regions that are involved in multiple RUNX1 translocations. These data suggest that RUNXOR noncoding RNA may function as a previously unidentified candidate component that is involved in chromosomal translocation in hematopoietic malignancies.